List of insiders holdings for Outlook Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Pillai Arun Kumar Director 10% Owner | 2022-02-01 17:09:01 | 0 25,482,529 | 25,482,529 | Form 4 |
| BioLexis Pte Ltd. 10% Owner | 2024-01-31 16:01:44 | 16,637,024 0 | 16,637,024 | Form 13D |
| Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 2024-03-20 17:24:26 | 9,266,645 0 | 9,266,645 | Form 13D |
| Mohan Pankaj Director 10% Owner | 2019-01-17 16:45:42 | 7,064,553 619,114 | 7,683,667 | Form 4 |
| Syntone Ventures LLC 10% Owner | 2024-04-17 21:38:26 | 2,776,867 0 | 2,776,867 | Form 13D |
| Dagnon Terry Chief Operations Officer | 2023-04-21 21:05:47 | 653,058 0 | 653,058 | Form 4 |
| Bahrt Kenneth Chief Medical Officer | 2019-02-19 20:23:56 | 600,000 0 | 600,000 | Form 4 |
| TRENARY C RUSSELL III CEO AND PRESIDENT | 2024-03-22 17:00:28 | 455,000 0 | 455,000 | Form 4 |
| Sukhtian Faisal Ghiath Director | 2024-10-03 20:30:09 | 210,837 0 | 210,837 | Form 4 |
| Haddadin Yezan Munther Director | 2024-10-03 20:30:10 | 208,700 0 | 208,700 | Form 4 |
| MCANDREW STEPHEN J SVP Bus. Strat. & Dev. | 2018-10-24 17:02:13 | 200,000 0 | 200,000 | Form 4 |
| HILZINGER KURT J Director | 2024-10-03 20:30:07 | 180,459 0 | 180,459 | Form 4 |
| THURMAN RANDY H Director | 2024-10-03 20:30:05 | 146,185 0 | 146,185 | Form 4 |
| Griffith Donald J. Director | 2016-11-28 21:59:48 | 144,926 0 | 144,926 | Form 4 |
| Windisch Joerg Director | 2018-11-13 16:57:57 | 130,465 0 | 130,465 | Form 4 |
| Gangolli Julian S Director | 2024-10-03 21:22:40 | 127,805 0 | 127,805 | Form 4 |
| Gangloff Scott A. SVP, Development & Mfrg | 2016-12-22 18:01:49 | 118,573 0 | 118,573 | Form 4 |
| Haller Julia A Director | 2024-10-03 20:30:18 | 115,950 0 | 115,950 | Form 4 |
| Auffarth Gerd Director | 2024-10-03 20:30:14 | 98,211 0 | 98,211 | Form 4 |
| Huang Andong Director | 2024-10-03 20:30:16 | 91,129 0 | 91,129 | Form 4 |
| Bao Kogan VP, Analytical Sciences | 2016-12-22 18:00:00 | 71,739 0 | 71,739 | Form 4 |
| Yamashita Elizabeth A. VP, Regulatory Affairs | 2017-12-26 17:07:26 | 64,648 0 | 64,648 | Form 4 |
| Thomas Joe Director | 2019-10-07 18:10:53 | 63,207 0 | 63,207 | Form 4 |
| Evanson Jeff CHIEF COMMERCIAL OFFICER | 2024-03-22 17:00:24 | 25,000 0 | 25,000 | Form 4 |
| Albrecht Claudio Director | 2017-11-02 18:13:52 | 25,000 0 | 25,000 | Form 4 |
| Brady Todd C Director | 2017-10-30 18:03:52 | 15,000 0 | 15,000 | Form 4 |
| Canute Scott A Director | 2017-10-30 18:02:53 | 15,000 0 | 15,000 | Form 4 |
| Dyrness Albert D. Director | 2017-10-30 18:01:52 | 15,000 0 | 15,000 | Form 4 |
| KENYON LAWRENCE A Chief Financial Officer | 2024-09-30 16:53:23 | 5,946 0 | 5,946 | Form 4 |
| Smith Hoke Robin Director | 2016-11-30 17:27:28 | 5,138 0 | 5,138 | Form 4 |